单细胞多组学测序揭示纺锤体移植后人类重构胚胎滋养外胚层与内细胞团染色体拷贝数不一致
本研究对30例不孕女性获得的45枚囊胚(22枚常规ICSI、23枚纺锤体移植后重构胚胎)行单细胞多组学测序,发现纺锤体移植囊胚中间型嵌合细胞谱系比例高于常规ICSI囊胚,且其滋养外胚层不能代表内细胞团的染色体拷贝数。
要点
- 纺锤体移植囊胚的滋养外胚层与内细胞团染色体一致性检验无统计学意义(P=1.000)。
- 常规ICSI囊胚的滋养外胚层与内细胞团显示良好染色体一致性(kappa=0.659,P<0.05)。
- 纺锤体移植囊胚中间型嵌合细胞谱系比例高于常规ICSI囊胚。
核心结论
- 纺锤体移植囊胚的滋养外胚层不能代表内细胞团的染色体拷贝数,且其中间型嵌合细胞谱系比例高于常规ICSI囊胚。
研究设计与样本
- 招募30例在本院接受治疗的不孕女性,获得45枚可用囊胚(22枚来自常规ICSI,23枚为纺锤体移植后重构胚胎)。
- 对所有囊胚行单细胞多组学测序,通过分析每枚囊胚中异常细胞比例确定染色体拷贝数,并用Bland-Altman一致性检验和Kappa检验评估两组滋养外胚层与内细胞团的一致性。
- 研究在中国一家公立三级医院进行,胚胎操作均在胚胎实验室完成,单细胞多组学测序在北京大学生命科学学院生物医学前沿创新中心完成。
主要发现
- 纺锤体移植组与ICSI组在志愿者平均年龄、囊胚形态和发育率方面相似。
- 纺锤体移植组囊胚除ICSI组囊胚富集的染色体类型外,还出现一些额外易变异的染色体类型。
- Bland-Altman一致性检验和Kappa检验均显示ICSI囊胚滋养外胚层与内细胞团染色体一致性良好(kappa=0.659,P<0.05),而纺锤体移植囊胚无统计学意义(P=1.000)。
- 基因功能注释(GO和KEGG分析)提示,与ICSI胚胎相比,纺锤体移植胚胎可能存在新的或额外的拷贝数变异产生通路。
临床怎么用
- 作者认为本研究支持在ICSI囊胚中常规临床使用PGT-A,因发现滋养外胚层可良好替代内细胞团预测染色体异常。
- 作者指出PGT-A并非完全准确,但数据显示其具有良好的临床可行性,可为患者提供关于PGT-A可靠性的正确遗传咨询。
- 作者认为纺锤体移植囊胚嵌合率增加及滋养外胚层不能代表内细胞团染色体拷贝数,是区别于ICSI囊胚的生物学特征。
- 作者指出目前纺锤体移植尚未在临床上大规模用于产生囊胚,但若未来更广泛应用,本研究首次提示在纺锤体移植囊胚中使用PGT-A可能不如ICSI囊胚的PGT-A准确。
局限性
- 本研究主要受限于样本量小和单细胞多组学测序技术的局限性。
- 为选择合格的单细胞,胚胎中部分细胞被排除或未被标记,导致这些细胞信息丢失。
- 本研究发现具有创新性和探索性,需要更大样本量的人类胚胎(尤其是纺锤体移植胚胎)和更准确的单细胞拷贝数变异分子遗传学技术来验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is the chromosome copy number of the trophectoderm (TE) of a human reconstituted embryos after spindle transfer (ST) representative of the inner cell mass (ICM)? SUMMARY ANSWER: Single-cell multi-omics sequencing revealed that ST blastocysts have a higher proportion of cell lineages exhibiting intermediate mosaicism than conventional ICSI blastocysts, and that the TE of ST blastocysts does not represent the chromosome copy number of ICM. WHAT IS KNOWN ALREADY: Preimplantation genetic testing for aneuploidy (PGT-A) assumes that TE biopsies are representative of the ICM, but the TE and ICM originate from different cell lineages, and concordance between TE and ICM is not well-studied, especially in ST embryos. STUDY DESIGN, SIZE, DURATION: We recruited 30 infertile women who received treatment at our clinic and obtained 45 usable blastocysts (22 from conventional ICSI and 23 reconstituted embryos after ST). We performed single-cell multi-omics sequencing on all blastocysts to predict and verify copy number variations (CNVs) in each cell. We determined the chromosome copy number of each embryo by analysing the proportion of abnormal cells in each blastocyst. We used the Bland-Altman concordance and the Kappa test to evaluate the concordance between TE and ICM in the both groups. PARTICIPANTS/MATERIALS, SETTING, METHODS: The study was conducted at a public tertiary hospital in China, where all the embryo operations, including oocytes retrieval, ST, and ICSI, were performed in the embryo laboratory. We utilized single-cell multi-omics sequencing technology at the Biomedical Pioneering Innovation Center, School of Life Sciences, Peking University, to analyse the blastocysts. Transcriptome sequencing was used to predict the CNV of each cell through bioinformatics analysis, and the results were validated using the DNA methylation library of each cell to confirm chromosomal normalcy. We conducted statistical analysis and graphical plotting using R 4.2.1, SPSS 27, and GraphPad Prism 9.3. MAIN RESULTS AND THE ROLE OF CHANCE: Mean age of the volunteers, the blastocyst morphology, and the developmental ratewere similar in ST and ICSI groups. The blastocysts in the ST group had some additional chromosomal types that were prone to variations beyond those enriched in the blastocysts of the ICSI group. Finally, both Bland-Altman concordance test and kappa concordancetest showed good chromosomal concordance between TE and ICM in the ICSI blastocysts (kappa = 0.659, P < 0.05), but not in ST blastocysts (P = 1.000), suggesting that the TE in reconstituted embryos is not representative of ICM. Gene functional annotation (GO and KEGG analyses) suggests that there may be new or additional pathways for CNV generation in ST embryos compared to ICSI embryos. LIMITATIONS, REASONS FOR CAUTION: This study was mainly limited by the small sample size and the limitations of single-cell multi-omics sequencing technology. To select eligible single cells, some cells of the embryos were eliminated or not labelled, resulting in a loss of information about them. The findings of this study are innovative and exploratory. A larger sample size of human embryos (especially ST embryos) and more accurate molecular genetics techniques for detecting CNV in single cells are needed to validate our results. WIDER IMPLICATIONS OF THE FINDINGS: Our study justifies the routine clinical use of PGT-A in ICSI blastocysts, as we found that the TE is a good substitute for ICM in predicting chromosomal abnormalities. While PGT-A is not entirely accurate, our data demonstrate good clinical feasibility. This trial was able to provide correct genetic counselling to patients regarding the reliability of PGT-A. Regarding ST blastocysts, the increased mosaicism rate and the inability of the TE to represent the chromosomal copy number of the ICM are both biological characteristics that differentiate them from ICSI blastocysts. Currently, ST is not used clinically on a large scale to produce blastocysts. However, if ST becomes more widely used in the future, our study will be the first to demonstrate that the use of PGT-A in ST blastocysts may not be as accurate as PGT-A for ICSI blastocysts. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by grants from the National Key R&D Program of China (2018YFA0107601) and the National Key R&D Program of China (2018YFC1003003). The authors declare no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Zhong W, Shen K, Xue X, et al. Single-cell multi-omics sequencing reveals chromosome copy number inconsistency between trophectoderm and inner cell mass in human reconstituted embryos after spindle transfer. Hum Reprod. 2023. PMID: 37766497. doi:10.1093/humrep/dead186
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。